Pomalidomide-C<SUB>6</SUB>-PEG<SUB>1</SUB>-C<SUB>3</SUB>-PEG<SUB>1</SUB>-butyl iodide CAS 1835705-76-4
| CAS No. | 1835705-76-4 |
| Molecular Formula | C30H42IN3O7 |
| Molecular Weight | 683.57 g/mol |
| Category | Pharmaceutical Standards / API Standards |
| Availability | In Stock |
Chemical Structure
Description
CATO supplies Pomalidomide-C<SUB>6</SUB>-PEG<SUB>1</SUB>-C<SUB>3</SUB>-PEG<SUB>1</SUB>-butyl iodide (CAS 1835705-76-4), a certified reference material (molecular formula C30H42IN3O7, MW 683.57 g/mol) for analytical method development and quality control.
Owing to a nitrogen-containing heterocyclic scaffold, an amide group, a hydroxyl group, an ether linkage, iodine substitution, Pomalidomide-C<SUB>6</SUB>-PEG<SUB>1</SUB>-C<SUB>3</SUB>-PEG<SUB>1</SUB>-butyl iodide is typically pale yellow to yellow amorphous powder. Its solid-state physicochemical attributes — including a molecular weight of 683.57 g/mol — guide the selection of appropriate sample preparation and analytical techniques. Nitrogen-containing functional groups confer excellent ionization efficiency in positive-ion electrospray (ESI) mode, making the compound well suited to LC-MS/MS analysis.
Recommended for analytical method development and validation; each product is supplied with a full Certificate of Analysis (COA) ensuring ISO 17034 metrological traceability.
CATO manufactures Pomalidomide-C<SUB>6</SUB>-PEG<SUB>1</SUB>-C<SUB>3</SUB>-PEG<SUB>1</SUB>-butyl iodide under ISO 17034:2016 accreditation with dual CNAS and ANAB accreditation. Each batch is characterized by orthogonal methods and supplied with a full Certificate of Analysis (COA), ensuring metrological traceability.
Physical & Chemical Properties
| Molecular Formula | C30H42IN3O7 |
| Molecular Weight | 683.57 g/mol |
| Purity | 97%+ |
| Storage | Store in a cool place (≤25°C), protect from light, keep sealed and dry |
| Solubility (reference) | Soluble in DMSO, DMF, methanol |
| Stability | May oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light; Hygroscopic; reseal immediately after opening; Contains ester bond; hydrolyzes under strong alkaline conditions |
| Degree of Unsaturation (DBE) | 11.0 |
| UV Absorption | UV-absorbing |
| Structural Features | Aromatic ring present |
| CAS Registry Year (est.) | 1995 |
| Halogen Content | I-containing |
| Nitrogen Atoms | 3 |
Related Pomalidomide Standards
- Pomalidomide-C<SUB>6</SUB>-PEG<SUB>3</SUB>-butyl iodide (CAS 1835705-70-8)
- Pomalidomide-C2-amido-(C1-O-C5-O-C1)2-COOH (CAS 2351103-63-2)
- Pomalidomide-amido-C4-amido-PEG2-C2-NH-Boc (CAS 2435720-04-8)
- Pomalidomide-PEG<SUB>6</SUB>-butyl iodide (CAS 1835705-74-2)
- Pomalidomide-amido-C4-amido-C6-NH-Boc (CAS 2435808-02-7)
- Pomalidomide-PEG<SUB>2</SUB>-butyl iodide (CAS 1835705-72-0)
- Pomalidomide-5'-PEG5-C2-acid (CAS 2412056-50-7)
- Pomalidomide Impurity 30 (CAS CATO-C4X-135430)
Recommended Standards
- Linagliptin impurity 119 (CAS CATO-C4X-1101119)
- Iron, [2,9-bis[3,5-bis(1,1-dimethylethyl)phenyl]-1,10-phenanthroline-κN1,κN10]dichloro-, (T-4)- (CAS 2173362-97-3)
- (Bromomethanetriyl)tris(benzene-4,1-diyl) tribenzoate (CAS 86610-66-4)
- Ni(4-Mestb)3 (CAS 2468315-68-4)
- Enrofloxacin (CAS 93106-60-6)
- 1-(2-Bromo-4-methylphenyl)-1h-pyrrole-2,5-dione (CAS 40011-62-9)
- (S)-2-hydroxypropanimidamide hydrochloride (CAS 1314999-69-3)
- 1-Methyl-1,4-dihydroquinoline-3-carbonitrile (CAS 72594-76-4)
- (8-Fluoroquinoxalin-6-yl)boronic acid (CAS 1248622-60-7)
- Brifentanil Hydrochloride (CAS 117268-95-8)
- 6-Hydroxy-6,7-dihydro-1H-indeno[5,6-c]furan-1,3(5H)-dione (CAS 2616551-97-2)
- methyl 5,7-dihydroxythieno[3,2-b]pyridine-6-carboxylate (CAS 90691-13-7)
- Gold Nitrate Hydrate (CAS 13464-77-2)
- Tetrapeptide-30/Tegopep (CAS 1036207-61-0)
Why CATO?
- ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
- 130,000+ catalog items in stock, COA supplied with every batch
- Worldwide shipping with full export documentation (HS code guidance available)
- Technical support: +86 18665070610 / Nicole.chen@cato-chem.com